Epidemiological treatment for chlamydia co-infection in men who have sex with men (MSM) with a presumptive diagnosis of urethral gonorrhoea in South Australia

The clinic works on a percentage of between 10% and 15% co-infection rates, with uncertainty as to what the cut-off should be, in terms of providing benefit to the individual, and the public health response to reduce the duration of infection.

Saved in:
Bibliographic Details
Published inSexually transmitted infections Vol. 88; no. 8; p. 580
Main Authors Khaw, Carole, Li, Bin, Waddell, Russell
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd 01.12.2012
BMJ Publishing Group LTD
Subjects
Audit
Chlamydia
Chlamydia trachomatis
Coinfection - drug therapy
Coinfection - epidemiology
epidemiology (clinical)
gay men
Gonorrhea - drug therapy
Gonorrhea - epidemiology
gonorrhoea
Humans
Infections
Lymphogranuloma Venereum - drug therapy
Lymphogranuloma Venereum - epidemiology
Male
South Australia - epidemiology
Urethritis - drug therapy
Urethritis - epidemiology
South Australia
South Australia Australia
Online AccessGet full text

Cover

More Information
Summary:The clinic works on a percentage of between 10% and 15% co-infection rates, with uncertainty as to what the cut-off should be, in terms of providing benefit to the individual, and the public health response to reduce the duration of infection.
Bibliography:local:sextrans;88/8/580
ArticleID:sextrans-2012-050687
PMID:22773325
href:sextrans-88-580.pdf
ark:/67375/NVC-S159SZPN-S
istex:D5235BF9D13C4BACE70F0BE36056FFCBAE126BEB
SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1368-4973
1472-3263
DOI:10.1136/sextrans-2012-050687